British Society for Rheumatology

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1038/s41467-020-19741-6 Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
https://doi.org/10.1002/art.20568 Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
https://doi.org/10.1126/science.abe1107 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
https://doi.org/10.1016/s0092-8674(00)81109-5 Rheumatoid Arthritis
https://doi.org/10.1002/art.1780400909 Range of antinuclear antibodies in “healthy” individuals
https://doi.org/10.1002/art.21978 Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
https://doi.org/10.1186/ar130 Mesenchymal precursor cells in the blood of normal individuals
https://doi.org/10.1136/annrheumdis-2013-205139 Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
https://doi.org/10.1136/ard.2008.096677 EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
https://doi.org/10.4049/jimmunol.178.12.7868 Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
https://doi.org/10.1016/j.cmet.2020.03.003 Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells
https://doi.org/10.1002/1529-0131(200011)43:11<2383::aid-anr2>3.0.co;2-d Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials
https://doi.org/10.1002/art.20982 Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
https://doi.org/10.1002/art.21678 Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial
https://doi.org/10.1186/cc5686 Management of bleeding following major trauma: a European guideline
https://doi.org/10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis
https://doi.org/10.1002/art.23138 Treg cells suppress osteoclast formation: A new link between the immune system and bone
https://doi.org/10.1136/annrheumdis-2011-200742 Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
https://doi.org/10.1136/ard.61.10.883 Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
https://doi.org/10.1093/rheumatology/36.2.239 Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
https://doi.org/10.1136/ard.2008.106351 Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus
https://doi.org/10.1093/rheumatology/38.10.917 A review of gastrointestinal manifestations of systemic lupus erythematosus
https://doi.org/10.4049/jimmunol.0803052 Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/ lpr Mice
https://doi.org/10.1111/bjd.15665 British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
https://doi.org/10.1136/ard.62.suppl_2.ii28 British Society for Rheumatology Biologics Register
https://doi.org/10.1136/ard.2008.090019 Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
https://doi.org/10.1136/ard.59.4.243 Cytokines and systemic lupus erythematosus
https://doi.org/10.1111/bjd.19039 British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
https://doi.org/10.1136/ard.2002.001826 Hepatic manifestations of autoimmune rheumatic diseases
https://doi.org/10.1093/rheumatology/keac551 British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
https://doi.org/10.1111/j.1365-2249.1993.tb03457.x Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor
https://doi.org/10.1136/annrheumdis-2011-201089 Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study
https://doi.org/10.1093/rheumatology/ker368 Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort
https://doi.org/10.1136/ard.2010.148502 Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
https://doi.org/10.1186/ar3910 B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
https://doi.org/10.1016/s1474-4422(19)30200-5 Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
https://doi.org/10.3389/fimmu.2018.03167 Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration
https://doi.org/10.1111/bjd.19621 British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020*
https://doi.org/10.1002/art.21661 Infliximab treatment maintains employability in patients with early rheumatoid arthritis
https://doi.org/10.1093/rheumatology/40.1.37 Total costs and predictors of costs in patients with systemic lupus erythematosus
https://doi.org/10.1111/jdv.14466 European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
https://doi.org/10.1177/0961203314547791 Anti-C1q antibodies in systemic lupus erythematosus
https://doi.org/10.1128/iai.00291-08 Impaired Opsonization with C3b and Phagocytosis ofStreptococcus pneumoniaein Sera from Subjects with Defects in the Classical Complement Pathway
https://doi.org/10.1177/0961203310385738 Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity
https://doi.org/10.1093/rheumatology/kep468 Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis
https://doi.org/10.1111/bjd.20524 British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021*
https://doi.org/10.1093/aje/kwn391 Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification
https://doi.org/10.1177/0961203310382429 The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
https://doi.org/10.1136/lupus-2015-000143 Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
https://doi.org/10.1136/annrheumdis-2019-216150 Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach
https://doi.org/10.1136/annrheumdis-2013-203933 Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
https://doi.org/10.1038/s41584-019-0240-8 Stratifying management of rheumatic disease for pregnancy and breastfeeding
https://doi.org/10.1183/13993003.01919-2020 JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk
https://doi.org/10.7861/clinmed.2020-0149 Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic
https://doi.org/10.1093/rheumatology/keae152 British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
https://doi.org/10.1371/journal.pone.0281156 Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
https://doi.org/10.1093/rheumatology/keac552 British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
https://doi.org/10.1016/s2665-9913(23)00215-1 Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
https://doi.org/10.1093/cei/uxae031 Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
https://doi.org/10.1093/rheumatology/keac558 Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
https://doi.org/10.1093/rheumatology/keac266 Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort study
https://doi.org/10.1002/acr.24849 Evaluating the Construct of Damage in Systemic Lupus Erythematosus
https://doi.org/10.1093/rheumatology/keae236 Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up
https://doi.org/10.1002/art.1780390702 Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
https://doi.org/10.1002/1529-0131(199807)41:7<1258::aid-art17>3.0.co;2-1 Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor ? and interleukin-1 in rheumatoid arthritis
https://doi.org/10.1136/ard.2003.013417 Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
https://doi.org/10.1002/1529-0131(199904)42:3<455::aid-anr10>3.0.co;2-3 A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities: I. Precision, sensitivity, and specificity
https://doi.org/10.1002/art.1780240103 Experimental intervertebral disc degeneration. morphologic and proteoglycan changes over time
https://doi.org/10.1038/labinvest.3780127 Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis
https://doi.org/10.1002/1529-0131(200011)43:11<2391::aid-anr3>3.0.co;2-f Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis
https://doi.org/10.1006/viro.1995.1442 Abundance of an Endogenous Retroviral Envelope Protein in Placental Trophoblasts Suggests a Biological Function
https://doi.org/10.1093/rheumatology/37.5.546 The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness
https://doi.org/10.1016/s0140-6736(87)92621-3 REDUCED B-CELL GALACTOSYLTRANSFERASE ACTIVITY IN RHEUMATOID ARTHRITIS
https://doi.org/10.1002/1529-0131(199901)42:1<90::aid-anr12>3.0.co;2-a Amelioration of collagen-induced arthritis and suppression of interferon-?, interleukin-12, and tumor necrosis factor ? production by interferon-? gene therapy
https://doi.org/10.1056/nejme048326 Statins for Atherosclerosis — As Good as It Gets?
https://doi.org/10.1016/s0049-0172(98)80040-1 Predictors of lymphoma development in primary Sjögren's syndrome
https://doi.org/10.1111/j.1365-2249.1995.tb08340.x Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA)
https://doi.org/10.4049/jimmunol.177.10.7416 Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus
https://doi.org/10.1093/rheumatology/38.11.1130 The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus
https://doi.org/10.1093/rheumatology/39.10.1147 Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review
https://doi.org/10.1093/rheumatology/40.12.1405 An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study
https://doi.org/10.1007/bf00489922 Limitations of safranin ?O? staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies
https://doi.org/10.1093/rheumatology/36.1.16 Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip
https://doi.org/10.4049/jimmunol.159.12.6253 Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram
https://doi.org/10.1189/jlb.72.4.800 IL-10 expression profiling in human monocytes
https://doi.org/10.1093/rheumatology/36.6.661 Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients
https://doi.org/10.1046/j.1365-2249.2003.02193.x Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis
https://doi.org/10.1177/0961203312436863 What do we know about self-reported fatigue in systemic lupus erythematosus?
https://doi.org/10.1186/ar110 Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis.
https://doi.org/10.1093/rheumatology/kem373 SLE patients with renal damage incur higher health care costs
https://doi.org/10.1093/rheumatology/38.10.968 A systematic review of treatments for the painful heel
https://doi.org/10.1007/s001980170035 Opinions and Experiences in General Practice on Osteoporosis Prevention, Diagnosis and Management
https://doi.org/10.1002/art.38133 Sulforaphane Represses Matrix‐Degrading Proteases and Protects Cartilage From Destruction In Vitro and In Vivo
https://doi.org/10.4049/jimmunol.0902765 Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways
https://doi.org/10.1097/00000372-200108000-00014 Everard Home, John Hunter, and Cutaneous Horns
https://doi.org/10.1136/ard.2005.042499 The British Society for Rheumatology Biologics Register
https://doi.org/10.4049/jimmunol.173.2.1266 Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway
https://doi.org/10.1007/s11136-004-6012-0 Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?
https://doi.org/10.1097/00007632-200207010-00010 A Pilot Study on the Recovery from Paresis After Lumbar Disc Herniation
https://doi.org/10.1046/j.1365-2249.2002.01735.x Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes